0
Dyne Therapeutics, Inc. Banner Image

Dyne Therapeutics, Inc.

  • Ticker DYN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Dyne Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Waltham, Massachusetts
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCEā„¢ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseasesMore, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD).
Dyne Therapeutics, Inc.

Most Recent Annual Report

Dyne Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Dyne Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!